124 related articles for article (PubMed ID: 38014509)
1. Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles.
Botti G; Bianchi A; Dalpiaz A; Tedeschi P; Albanese V; Sorrenti M; Catenacci L; Bonferoni MC; Beggiato S; Pavan B
Expert Opin Drug Deliv; 2023; 20(11):1657-1679. PubMed ID: 38014509
[TBL] [Abstract][Full Text] [Related]
2. Effects of Microencapsulated Ferulic Acid or Its Prodrug Methyl Ferulate on Neuroinflammation Induced by Muramyl Dipeptide.
Botti G; Bianchi A; Pavan B; Tedeschi P; Albanese V; Ferraro L; Spizzo F; Del Bianco L; Dalpiaz A
Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078325
[TBL] [Abstract][Full Text] [Related]
3. Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles.
Dalpiaz A; Ferraro L; Perrone D; Leo E; Iannuccelli V; Pavan B; Paganetto G; Beggiato S; Scalia S
Mol Pharm; 2014 May; 11(5):1550-61. PubMed ID: 24717116
[TBL] [Abstract][Full Text] [Related]
4. Characterization and Hydrolysis Studies of a Prodrug Obtained as Ester Conjugate of Geraniol and Ferulic Acid by Enzymatic Way.
Lerin LA; Botti G; Dalpiaz A; Bianchi A; Ferraro L; Chaibi C; Zappaterra F; Meola D; Giovannini PP; Pavan B
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892454
[TBL] [Abstract][Full Text] [Related]
5. Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries.
Dalpiaz A; Fogagnolo M; Ferraro L; Capuzzo A; Pavan B; Rassu G; Salis A; Giunchedi P; Gavini E
Antiviral Res; 2015 Nov; 123():146-57. PubMed ID: 26427553
[TBL] [Abstract][Full Text] [Related]
6. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles.
Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A
Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid microparticles for the stability enhancement of a dopamine prodrug.
Dalpiaz A; Cacciari B; Mezzena M; Strada M; Scalia S
J Pharm Sci; 2010 Nov; 99(11):4730-7. PubMed ID: 20845469
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition study.
Martignoni I; Trotta V; Lee WH; Loo CY; Pozzoli M; Young PM; Scalia S; Traini D
J Microencapsul; 2016 Dec; 33(8):735-742. PubMed ID: 27841060
[TBL] [Abstract][Full Text] [Related]
9. Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease.
de Oliveira Junior ER; Truzzi E; Ferraro L; Fogagnolo M; Pavan B; Beggiato S; Rustichelli C; Maretti E; Lima EM; Leo E; Dalpiaz A
J Control Release; 2020 May; 321():540-552. PubMed ID: 32092370
[TBL] [Abstract][Full Text] [Related]
10. Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery.
Dalpiaz A; Fogagnolo M; Ferraro L; Beggiato S; Hanuskova M; Maretti E; Sacchetti F; Leo E; Pavan B
Eur J Pharm Biopharm; 2019 Nov; 144():91-100. PubMed ID: 31521715
[TBL] [Abstract][Full Text] [Related]
11. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.
Yadav VR; Suresh S; Devi K; Yadav S
J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903
[TBL] [Abstract][Full Text] [Related]
12. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
Gavini E; Rassu G; Ferraro L; Beggiato S; Alhalaweh A; Velaga S; Marchetti N; Bandiera P; Giunchedi P; Dalpiaz A
Eur J Pharm Biopharm; 2013 Feb; 83(2):174-83. PubMed ID: 23153670
[TBL] [Abstract][Full Text] [Related]
13. Brain uptake of an anti-ischemic agent by nasal administration of microparticles.
Dalpiaz A; Gavini E; Colombo G; Russo P; Bortolotti F; Ferraro L; Tanganelli S; Scatturin A; Menegatti E; Giunchedi P
J Pharm Sci; 2008 Nov; 97(11):4889-903. PubMed ID: 18300305
[TBL] [Abstract][Full Text] [Related]
14. Co-loading of a photostabilizer with the sunscreen agent, butyl methoxydibenzoylmethane in solid lipid microparticles.
Scalia S; Mezzena M
Drug Dev Ind Pharm; 2009 Feb; 35(2):192-8. PubMed ID: 18785040
[TBL] [Abstract][Full Text] [Related]
15. L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.
Puris E; Gynther M; Huttunen J; Auriola S; Huttunen KM
Eur J Pharm Sci; 2019 Mar; 129():99-109. PubMed ID: 30625368
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid microparticles for the stability enhancement of the polar drug N6-cyclopentyladenosine.
Dalpiaz A; Mezzena M; Scatturin A; Scalia S
Int J Pharm; 2008 May; 355(1-2):81-6. PubMed ID: 18178347
[TBL] [Abstract][Full Text] [Related]
17. S/O/W microparticles prepared with hydroxyethyl starch-based emulsifier showed reduced macrophage affinity.
Li Q; Fan X; Pan X; Yu Y; Jian L; Zhang Y; Yin T; He H; Tang X; Jin J; Gou J
Colloids Surf B Biointerfaces; 2022 Dec; 220():112917. PubMed ID: 36272284
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid micro-dispersions (SLMs) based on PEGylated solidified reverse micellar solutions (SRMS): a novel carrier system for gentamicin.
Kenechukwu FC; Momoh MA; Nnamani PO; Attama AA
Drug Deliv; 2015; 22(6):710-22. PubMed ID: 24724962
[TBL] [Abstract][Full Text] [Related]
19. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the properties of Gongronema latifolium in phospholipon 90H based solid lipid microparticles (SLMs): an antidiabetic study.
Chime SA; Onyishi IV; Ugwoke PU; Attama AA
J Diet Suppl; 2014 Mar; 11(1):7-18. PubMed ID: 24409977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
